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Abstract
Background: The purpose of this study was to investigate in oral breathing children the qualitative
and quantitative effects on aerobic and facultatively anaerobic oropharyngeal microflora of
respiratory function improved by rapid palatal expansion (RPE).
Methods: In an open clinical trial, we studied 50 oral breathers, aged 8 to 14 years and suffering
from both maxillary constriction and posterior cross-bite. At baseline, patients were examined by
a single otorhinolaryngologist (ENT), confirming nasal obstruction in all subjects by posterior
rhino-manometric test. Patients were evaluated three times by oropharyngeal swabs:1) at baseline
(T = 0); 2) after palatal spreading out (T = 1); and 3) at the end of RPE treatment (T = 2). With
regard to the microbiological aspect, the most common and potentially pathogenic oral
microrganisms (i.e. Streptococcus pyogenes, Diplococcus pneumoniae, Staphylococcus aureus,
Haemophilus spp, Branhamella catarrhalis, Klebsiella pneumoniae, Candida albicans) were
specifically detected in proper culture plates, isolated colonies were identified by means of
biochemical tests and counted by calibrated loop. The data were analyzed by means of the following
tests: Chi-square test, Fisher's exact test and Wilcoxon's test.
Results: After the use of RME there was a statistically significant decrease of Staphylococcus
aureus stock at CFU/mLat T1(P = 0.0005; Z = -3,455 by Wilcoxon Rank test) and T2 (P < 0.0001;
Z = -4,512 by Wilcoxon Rank test) vs T0. No significant changes were found for the other
examined microrganisms.
Conclusion:  Our data suggest that RPE therapy in oral breathers may strongly reduce the
pathogenic aerobic and facultatively anaerobic microflora in the oral pharynx after a normalization
of the upper airways function, and may reduce the risk of respiratory infections.
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Background
Aerobic and facultative anaerobic bacteria are prevalent
among the bacterial populations of the human body, par-
ticularly on mucous membrane surfaces. In the oral cavity
these bacteria are found on the tooth surface (above all in
subgingival plaque), in the saliva, on the tongue surface
and in the tonsillar crypts. [1]
Genera commonly found in the oral cavity are Actinomy-
ces, Arachnia, Bacteroides, Bifidobacterium, Eubacterium,
Fusobacterium, Lactobacillus, Leptotrichia, Peptococcus,
Streptococcus, Propionibacterium, Selenomonas,
Treponema, and Veillonella. [2]
Their role in dental caries, periodontal disease, root canal
infections, infections of the hard and soft oral tissue, as
well as their importance as foci for disseminated infec-
tious disease is well established. Poor oral hygiene and
periodontal disease may promote oropharyngeal coloni-
zation by potential respiratory pathogens (Klebsiella
pneumoniae, Pseudomonas aeruginosa, Staphylococcus
aureus, etc.). [3] Furthermore, aerobes and facultative
anaerobes are the most numerous components of the nor-
mal human oropharyngeal bacterial flora, and they are
therefore a common cause of bacterial infections of the
upper respiratory tract which have an endogenous origin
(bronchitis, sinusitis, otitis, pneumonia) [4]; in addition
to bacteria, fungi, mainly represented by Candida albicans,
may colonise the oral ecosystem as well as protozoan.
(Table 1)
In detail, Staphylococci spp are Gram+ bacteria aerobic and
facultative anaerobic, round and with a diameter of 0,8-1;
they are normally located at every site of the human body
(skin, conjunctiva, nose, pharynx, mouth, lower intestine,
anterior urethra, vagina). The most important species is S.
aureus, responsible for soft tissue pathologies like abscess,
stomatitis, angular cheilitis, maxillary osteomyelitis, mas-
toiditis and parotitis [5]. The enzymes produced by S.
aureus and released outside the cell are several, some in
direct relation to its pathogenic activity (a-, β- and t-
emolisin, coagulase, hyaluronidase, exfoliatin, leucoci-
din, lipase [6], and staphylokinase). Also, Streptococci spp
are Gram+ bacteria aerobic and facultative anaerobic, cap-
sulate and stationary; they are round, from 1 to 15 µ in
diameter and disposed in couples or a chain. Different
streptococcal species are present on skin and mucous sur-
faces (mouth, pharynx, intestine, trachea, vagina), consti-
tuting the majority of the oropharyngeal microbial
population. Most of them may cause several diseases espe-
cially local septic lesions (e.g. tonsillitis, otitis, dental
abscess, caries, pharyngitis), flogistic processes in a cavity
(e.g. meningitis, pleurisy, pneumonia), systemic diseases
(e.g. septicaemia, rheumatic fever) or a fibrin vegetation
in a cardiac valve [7]. Neisserie and Branhamella spp are
Gram- cocci, they may be aerobe or anaerobe, stationary,
asporogenous and often with a capsule. N. meningitidis
represents actually a pathogenic species for human
meningeal suppurating infections [8].
Branhamella catarrhalis, an inhabitant of the upper respira-
tory tract, is an important cause of a pathological process
(bronchitis, maxillary sinusitis, meningitis, endocarditis,
otitis and pneumonia) [10].
Haemophilus influenzae is one the most important and fre-
quent etiologic agent of meningeal infections, laryngitis,
endocarditis or respiratory infections in children [9].
Klebsiella pneumoniae is present in the pharynx of only 1–
6% of sound people. Causes a serious, often fatal, pneu-
monia principally in debilitated patients [11].
In this complex microbiological scenario, the respiratory
function has got a notable influence not only on the oral
habitat but also on the development of the stomatognatic
system; indeed, correct respiratory dynamics, through the
nasal cavity, are a fundamental stimulus for its anatomical
development. Especially in childhood, human beings
may breath orally with several immediate and long-stand-
ing consequences. The anatomical picture in an oral
breather, with a contraction of transversal diameters of the
upper maxilla (ogival palatal shape and bilateral cross-
Table 1: Bacteria commonly found on the surfaces of the pharynx
Staphylococcus epidermidis ++ Streptococcus pyogenes* + Mycoplasmas +
Staphylococcus aureus* + Neisseria sp.+ + Mycobacteria +/-
Streptococcus mitis + Klebsiella pneumoniae +/- Lactobacillus sp.+
Streptococcus salivarius ++ Neisseria meningitidis* ++ Hemophilus influenzae +
Streptococcus mutans * + Corynebacteria + Pseudomonas aeruginosa +/-
Enterococcus faecalis* +/- Actinomycetes + Proteus +
Streptococcus pneumoniae + Spirochetes + Enterobacteriaceae (Escherichia coli)* +/-
++ = nearly 100% + = common +/- = rare * = potential pathogen.
Asterisks indicate members of the normal flora that may be considered major pathogens of humans.BMC Oral Health 2006, 6:2 http://www.biomedcentral.com/1472-6831/6/2
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bite) is the consequence of an increased resistance of the
nasal ways to the flow of air.
For this kind of orthodontic problem, the primary thera-
peutic approach is the use of a rapid palatal expansor
(RPE), which determines a sudden non-surgical detach-
ment of the palatal bones by use of force (> 500 gr), over
a short period of time. The rapid palatal expansor was
firstly invented and described by E.H. Angell in 1860;
however this technique only became widespread in the
70s'. The primary aim of this device is to provide a lateral
expansion force of such an intensity as to verify the move-
ment of the basal maxillary bones at the suture level
(median palatal, maxillary-zygomatic and pterigo-maxil-
lary sutures) instead of a simple re-modelling of the alve-
olar arch. At the synfibrosis stage the bony surfaces will
rapidly detach and this space will be occupied by fibrous
connective tissue which will soon change into a bony
structure.
The application of such an apparatus determines the fol-
lowing results:
• an enlargement of the upper maxillary osseous base and
its equilibrium with the mandible base;
• certain degree of nasal septum deviation correction
• significant reduction in nasal resistance [12]
• an improvement of respiratory functions [13]
Several researchers observed significant changes in the
microflora of the nasopharynx in children subjected to
adenoidectomy for chronically hypertrophied and
infected adenoids [14,15], but nobody investigated a cor-
relation between RPE, reduction in nasal resistance and
pharyngeal microflora.
The aim of the present study was to verify if RPE therapy
is able to determine changes in the oral microflora among
oral breathing children.
Methods
Sample
In the present open clinical trial, the study group was
recruited in secondary hospital base and composed of 50
children (range 8–14 years), consecutively admitted for
orthodontic treatment (i.e. RPE). Inclusion criteria were
European ethnic origin and mouth breathing reported by
parents and clinically observed by a dentist specialist in
Orthodontics. A child has been considered as an oral
breathers if his/her mouth is open at rest, tension of peri-
oral muscles is visible when the mouth is closed, he/she
complains about nasal obstruction and more often
breathes through the mouth [16]. Exclusion criteria were
nasal allergic conditions or airway obstruction due to ade-
noids and previous orthodontic treatment. Subjects did
not undergo any type of antibiotic treatment or pharma-
cological therapy during the observation period which
lasted 6 months. The expansion regimen was of 3 turns/
day (1 turn = 0.2 mm), until the required expansion was
achieved. After the end of the ERP successful active phase,
the appliance was left in place for 6 months. Even if the
controlled clinical trials represent the ideal study design,
we decided against this approach on ethical grounds in
view of the severe clinical condition of the patient.
Clinical recordings
The first step was that all patients were examined by a sin-
gle ENT. Nasal obstruction was confirmed by posterior
rhynomanometric test, performed at ENT Clinic (Univer-
sity of Bari, Bari, Italy) using Athos 300 rhino-manometer,
according to the protocol recommended by the Manufac-
turer.
Three consecutive pharyngeal swabs were carried out: the
1st before application of RPE (T = 0), the 2nd after palatal
spreading out (T = 1), and the 3rd at the end of RPE treat-
ment (T = 2). Microbiologically, we looked for the follow-
ing microrganisms: Streptococcus pyogenes, Diplococcus
pneumoniae, Staphylococcus aureus, Haemophilus spp, Bra-
nhamella catarrhalis, Klebsiella pneumoniae, Candida albi-
cans.
It is a question of microrganisms that may be considered
major pathogens of humans.
Each microbiologic sample carried out in the posterior
pharynx and palatal tonsillar was repeated three times
with different sterile swabs. Two swabs were directly used
for seeding in culture plates, the third was saved with 500
µl of sterile saline and underwent vortex for 1 min. The
obtained suspension was used for further seeding with a
10 µl of seed medium. Specifically, to detect Streptococci,
5 ml of Streptococcus broth were added to the residual
saline; this broth is useful for Streptococcus isolation and
their culture was subsequently performed on blood Agar
(5% lamb red blood cells which inhibit Haemophilus
haemoliticus), by adding Optochine which is an inhibitor
of Diploccocus pneumoniae and Bacitracine which inhibits
Streptococcus pyogenes. Further species were identified by
means of biochemical tests.
In order to detect the Staphylococcus aureus a Chapman
broth was used (75% NaCl, mannitole, phenole red); col-
onies found as positive for pathogens underwent a coagu-
lase test. In order to search for Neisseria and Hemophilus
spp: agar-blood incubated at 5–10% CO2 and agar-choco-
late incubated at 35° were respectively used. To detectBMC Oral Health 2006, 6:2 http://www.biomedcentral.com/1472-6831/6/2
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Enterobacteria, Agar Mac-ConcKey (biliary salts, red neu-
tral lactose) was used; for mycetes: Agar- Sabouraud (dex-
trose, peptone) with cloramphenicole and gentamicine as
bactericides was used. Identification of Candida albicans,
the only fungal species observed, was made after incuba-
tion in blood serum at 37°C for 2–3 hours; the compari-
son between germinative tubules and pseudo-hyphae, the
observation of Albicans ID2 containing chromogenic
exosamine were also carried out. After the surface sowing
on plate for spatulation and opportune incubation, we
proceeded to enumeration of the positive cultures for the
species searched and count of the number of colonies
which developed for single plate (vital count, count in
plate or count of the colonies), which is correlated to the
explored anatomic zone numerousness. It has been indi-
cated the number of colonies growing on each plate and
expressed by Colony Forming Unit (CFU/ml). Two count
methods can be distinguished:
-direct method (it uses the corpuscles count chamber and
it counts both alive cells and dead cells);
-indirect method or of the vital count or count in plate or
count of the colonies, sow and subsequent counting of the
developed colonies (sensible method). We count only the
alive cells which are able to proliferate and form colonies
on suitable agaric land. The microbiological research of
Streptococcus pyogenes, showed only the presence or not of
microrganisms. After the end of RPE treatment, no poste-
rior rhino-manometric test was performed again, since
this datum did not constitute a major end-point of the
trial.
Statistical analysis
Data were analyzed by means of the computer packages S-
Plus 4.0 (Cambridge, UK). The Chi-square test was used
to assess statistical differences among categorical varia-
bles; Fisher's exact test was used when the frequency
observed was less than 5; in all the evaluations p-values =
0.05 were considered statistically significant. Further-
more, in order to evaluate significance of differences
(expressed in CFU/ml) at T = 0, T = 1 and T = 2 the Wil-
coxon's test was used.
Results
Microbiological findings are described in Table 2. In
detail,  Streptococcus pyogenes was present in 5 patients
(10%) at T0, in the same 5 patients at T1, and then disap-
peared at T2, although the difference did not reach statis-
tical significance (P = 0,07). Neisseria meningitis,
Diplococcus pneumoniae and Haemophilus spp were not
found in none of the 50 patients at T0, T1 and T2. A sig-
nificant difference was found for Klebsiella pneumoniae and
Branhamella catarrhalis, both present in 5 patients at T0
(10%) and in no patient at T1 and T2 (P = 0,006). Candida
albicans  was found in 15 patients (30%) at T0, in 19
(38%) at T1 and in 10 (20%) at T2, without any signifi-
cant change (P = 0,141), the same for Staphylococcus
aureus- stock b, which was found in 8 patients (16%) at To
and at T1, and in 2 patients (4%) at T2 (P = 0,103). A sig-
Table 2: Species and frequency rates at T0, T1 and T2 in a sample investigated (n = 50)
S p e c i e s T 0T 1T 2X 2 P*
Candida albicans 30% (15/50) 38% (19/50) 20% (10/50) 3,924 0,141
Staphylococcus aureus- stock a 74% (37/50) 68% (34/50) 44% (22/50) 10,696 0.005*
Staphylococcus aureus- stock b 16% (8/50) 16% (8/50) 4% (2/50) 4,545 0,103
Branhamella catarrhalis 10% (5/50) 0 0 10,345 0,006*
Neisseria meningitidis 000- -
Klebsiella pneumoniae 10% (5/50) 0 0 10,345 0,006*
Haemophilus 000- -
Diplococcus pneumoniae 000- -
Streptococcus pyogenes 10% (5/50) 10% (5/50) 0 5,357 0,069
*by means of Chi-Square test
Table 3: Means ± DS of the CFU/mL of the main species detected at T0, T1 and T2, respectively.
Species* T0 T1 Z P** T0 T2 Z P**
Staph.aureus stock a 28,23 (± 53,96) 5,48 (± 5,10) -3,455 0,0005 28,23 (± 53,96) 3,07 (± 6,08) -4,512 0,0001
Staph.aureus stock b 5,23 (± 9,13) 3,46 (± 3,30) -0,105 0,916 5,23 (± 9,13) 2 (± 4,88) -2,521 0,011
Candida 5,95 (± 5,20) 1,8 (± 1,00) -3,267 0,0011 5,95 (± 5,20) 2,25 (± 3,04) -1,792 0,07
*For Branhamella catarrhalis, Neisseria meningitidis, Klebsiella pneumoniae, Haemophilus, Diplococcus pneumoniae and Streptococcus pyogenes
CFU/mL values were found in little number of patients and quantity, not adequate for statistical analysis.
**by means of Wilcoxon Signed Rank Test.BMC Oral Health 2006, 6:2 http://www.biomedcentral.com/1472-6831/6/2
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nificant variation was found in the three therapy steps for
Staphylococcus aureus – stock a present in 37 patients
(74%) at T0 in 34 (68%) at T1 and in 22 (44%) at T2(P
0,005).
The involvement of a greater number of patients from
these last three microbic species allowed the use of the
Wilcoxon Signed Rank test in order to evaluate differences
expressed in CFU/ml (see Table 3). It was evaluated signif-
icant the decrease caused by RPE treatment at T0 vs T1 (Z
-3,455; P = 0.0005) and at T0 vs T2 (Z -4,512, P = 0,0001)
for Staphylococcus aureus-stock a and at T0 vs T1 for Cand-
ida albicans (Z -3,267; P = 0,0011). There are no significant
changes at T0, T1 and T2 for Staphylococcus aureus- stock b
and for Candida albicans at T0 vs T2.
Discussion
The orthodontic relevance of nasal obstruction and its
presumed effect on facial growth and head posture con-
tinues to be debated. The growth of the maxilla depends
on the hormone activity, passive activities (i.e. sutures) as
well as active dynamics. The lateral expansion of the max-
illa is directly conditioned by the development of the
nasal capsula and pterigoid floors and indirectly by the
expansion of the eyeballs [17]., KIThe main characteristics
of nasal obstruction are mouth breathing, open bite,
cross-bite, narrow external nostrils [18]. Other features
include an increase in lower facial height, incompetent lip
posture, right angle of the mandibular plane and V-
shaped maxillary arch [19]. The clinical extra-oral picture
in these patients is conspicuous and is labelled as 'adenoi-
dal faces'.
Oral respiration disrupts those muscle forces exerted by
tongue, cheeks and lips upon the maxillary arch. Intra-
orally, the dentist might expect to find a narrow maxillary
arch with a high palatal vault, a posterior cross-bite, a class
II or III dental malocclusion, open-bite.
RME is the primary device used in the orthodontic treat-
ment of insufficient transverse dimension of the maxillary
base [20]. The treatment with RME determines an
improvement of respiratory function [21]. A large number
of bacterial species heavily colonize the upper respiratory
tract (nasopharynx). The predominant species are non-
hemolytic and alpha-hemolytic streptococci and neisse-
ria, but sometimes pathogens such as Streptococcus pneu-
moniae,  Streptococcus pyogenes,  Haemophilus influenzae,
Neisseria meningitides and Staphylococcus aureus colonize
the pharynx. A reduction in ventilation through the nasal
cavity may allow a permanence of mucous secretions,
which modify microbial growth and leads to upper respi-
ratory tract infection. The literature indicates that the spe-
cies responsible for this latter condition are the following:
Staphylococcus aureus, Streptococcus pyogenes, Streptococcus
Enterobactery, Streptococcusα-haemolytic, Neisseriaceae, Sta-
phylococcus aureus, Pneumococcus, Streptococcus β-haemolytic
group A, Streptococcus β-haemolytic non A, Pseudomonas aer-
uginosa, Haemophilus influenzae, Branhamella catarrhalis
[14].
The purpose of this study was to verify if rapid palatal
expansion was able to determine quantitative and qualita-
tive changes in anaerobic and facultative anaerobic pha-
ryngeal micro-flora in young oral breathers, an issue not
properly estimated in so far.
Our main finding is that pathogenic micro-flora of the
oral pharynx may be reduced after the use of RPE in oral
breathers. In particular, we observed in breathers a nota-
ble presence, at baseline, of Staphylococcus aureus, an
important pathogen, and its reduction after RME. Candida
albicans showed a particular pattern with an initial reduc-
tion (T0 vs T1) with a successive re-colonization at T2 in
the same patients, likely due to a persistence of different
predisposal factors [22,23] or, in some cases, colonized
some of them ex novo. Although in a little sample size and
without controls, the findings of this study suggest that
the improvement of nasopharyngeal airway adequacy
RME-related is associated to a decreased presence of Sta-
phylococcus aureus-stock a. The long-term benefits of the
RPE- therapy in terms of respiratory infections was not
investigated. Further studies with larger numbers of
patients, presence of a control group and more details of
the clinical status regarding the frequency of infections,
may be required for further evaluation of this interesting
issue.
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